We assume that, in our setting, the tumor cells attract and activate platelets through either tumor cell podoplanin-platelet CLEC-2 [40, 41] or tumor cell integrin-vWF-platelet GPIb interactions [42]. Here, CLEC1B is linked to neoplasm.